WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: APRIL ISSUE PUBLISHED
  • April Issue has been successfully launched on 1 April 2024.

Abstract

A CASE REPORT OF METHYLOBACTERIUM RADIOTOLERANS BACTEREMIA IN A HAEMODIALYSIS PATIENT SUCCESSFULLY TREATED BY COMBINATION THERAPY OF LEVOFLOXACIN AND MEROPENEM

Dr Kalidas Rit*, Dr Bipasa Chakraborty, Dr Tapajyoti Mukherjee, Dr Parthasarathi Chakrabarty

ABSTRACT

Central venous catheters (CVCs) play an important role in replacement therapy for patient with renal diseases. Secondary infections due to central venous access are responsible for 48-73% bacteremia in haemodialysis patient and important cause of morbidity. Here we describe a patient with hospital -acquired bacteremia caused by Methylobacterium radiotolerans which was successfully treated by combination therapy of levofloxacin and meropenem

Keywords: Central venous catheters, bacteremia, Methylobacterium radiotolerans.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More